Lv11
30 积分 2024-01-23 加入
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
3小时前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
1个月前
已完结
Developing CAR T-Cell Therapies for Pediatric Solid Tumors
4个月前
已完结
Current status of CAR-T cell therapy for pediatric hematologic malignancies
4个月前
已完结
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
4个月前
已完结
CAR T-cells for acute leukemias in children: current status, challenges, and future directions
4个月前
已完结
CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results
4个月前
已完结
Tisagenlecleucel in practice: Real-world lessons in pediatric and young adult B-ALL
4个月前
已完结
Hypoxia-Responsive CAR-T Cells Exhibit Reduced Exhaustion and Enhanced Efficacy in Solid Tumors
6个月前
已完结
皖公网安备34019202002308
